Establish a Real World Evidence Strategy Throughout the Product Lifecycle to Articulate Product Value and Encourage Cross-stakeholder Partnerships with Payers, Providers and Regulatory Bodies
As value-based healthcare continues to transform and changes to FDA Regulations provide pathways to accelerated drug approvals, there is opportunity to leverage real-world data and evidence to establish cross-stakeholder partnerships, improve health outcomes and differentiate a product and brand in the market. The Real-World Data and Evidence Track will showcase successful strategies for optimizing real world data across the product lifecycle, highlight application of use cases, methodologies to assess data, analytical tools, and strategies for implementing end-to-end evidence management.
- Utilize real-world evidence to demonstrate both clinical and cost-effectiveness of your product to payers and providers
- Explore payer, health system and regulatory perspectives to create cross-stakeholder partnerships and better understand acceptance criteria
- Leverage real-world evidence to optimize clinical development and accelerate drug discovery
- Discover digital applications to optimize real- world evidence collection
The PDF brochure for the 2nd Annual Real-World Data and Evidence Track is in production. Request it now and our Customer Service team will contact you once the brochure becomes available.
Topic Areas Include:
Call for Papers
Submit Abstract for Presentations
2nd Annual Real-World Data and Evidence Track is now accepting abstract submissions for 2020!
Deadline is May 1st, 2020.
Benefit from one-on-one meetings, corporate branding and relationship building by participating as an active corporate supporter and sponsor. World Congress offers various levels of support and sponsorship opportunities. To learn more contact:
Vice President of Sales